DUBLIN, Mar. 24, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/krh74h/global) has announced the addition of the "Concise Analysis of the International Epigenetics Market - Forecasts to 2018" report to their offering.
Along with oncology indications, epigenetic drugs also find application in non-oncology indications such as inflammatory diseases, autoimmune diseases, neurodegenerative disorders, and personalized medicine. These are some of the high growth and emerging areas that are expected to drive the Global Epigenetics market in the future. Current treatments for chronic and degenerative disorders are in many cases inadequate or very expensive. Epigenetic drugs are attractive options for treating such disorders because they manipulate the processes that maintain cells in an abnormal transcriptional state.
According to the report, one of the main drivers propelling the growth of the market is the steadily growing aging population worldwide. There is a strong correlation between cancer and aging. The number of patients suffering from cancer is increasing owing to the increasing aging population, both in developing and developed nations.
Further, the report states that one of the major challenges faced by the market is the patent expiries of major drugs. Patent expiries erode the revenue potential of the market and affect the market negatively.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Key Topics Covered:
1. Executive Summary
2. List of Abbreviations
3. Scope of the Report
4. Market Research Methodology
6. Market Landscape
7. Market Segmentation by Mechanism of Action
8. Geographical Segmentation
9. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
17. Key Vendor Analysis
18. Other Reports in this Series
- Celgene Corp.
- Eisai Inc.
- Merck & Co.
For more information visit http://www.researchandmarkets.com/research/krh74h/global
Media Contact: Laura Wood , +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets